Fund HoldingsB Group, Inc.

Total Portfolio Value
$115.09M
Total Bought
$18.20M
Total Sold
$64.73M
Net Transaction
-$46.54M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
ADMA BIOLOGICS INC2,287,5422,317,542+30,00039,23145,98039.95%+6,749
ZAI LAB LTD(ZLAB)400,000400,000010,47614,45612.56%+3,980
AKERO THERAPEUTICS INC260,000242,500-17,5007,2339,8168.53%+2,583
ULTRAGENYX PHARMACEUTICAL IN(RARE)7,59647,500+39,9043201,7201.49%+1,400
ULTRAGENYX PHARMACEUTICAL IN(Call)
CALL
037,600+37,60001,361+1,361
ASSEMBLY BIOSCIENCES INC50,651200,000+149,3497991,9121.66%+1,113
BIONTECH SE(BNTX)3,50015,000+11,5003991,3661.19%+967
PRAXIS PRECISION MEDICINES I(PRAX)019,000+19,00007200.63%+720
89BIO INC095,623+95,62306950.60%+695
APOGEE THERAPEUTICS INC(APGE)15,00030,000+15,0006801,1210.97%+441
CORVUS PHARMACEUTICALS INC(CRVS)(Put)090,000+90,0000286+286
ORUKA THERAPEUTICS INC(ORKA)20,00058,215+38,2153885970.52%+209
TAYSHA GENE THERAPIES INC(TSHA)965,5561,255,556+290,0001,6701,7451.52%+75
SPYRE THERAPEUTICS INC(SYRE)50,00070,000+20,0001,1641,1290.98%-35
SIGHT SCIENCES INC629,370833,600+204,2302,2912,0011.74%-290
CORVUS PHARMACEUTICALS INC(CRVS)100,0000-100,0005350-535
AURA BIOSCIENCES INC472,576472,57603,8852,7692.41%-1,115
ULTRAGENYX PHARMACEUTICAL IN
CALL
29,5000-29,5001,2410-1,241
CELLECTIS S A3,081,5013,256,501+175,0005,5474,0383.51%-1,509
IOVANCE BIOTHERAPEUTICS INC(IOVA)992,0001,500,000+508,0007,3414,9954.34%-2,346
INSMED INC(INSM)350,000262,500-87,50024,16420,02617.40%-4,138
INVESCO QQQ TR110,0000-110,00056,2350-56,235
Page 1 of 1